D Tovi. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AdultAgedAntifibrinolytic AgentsBlood Cell CountCerebral AngiographyCyclohexanecarboxylic Acids/therapeutic useFactor IXFactor VFactor VIIFactor XFemaleFibrin/cerebrospinal fluidFibrin/metabolismFibrinogen/metabolismFibrinolytic Agents/bloodFibrinolytic Agents/cerebrospinal fluidHumansHydralazine/therapeutic useIntracranial Aneurysm/drug therapyMaleMethyldopa/therapeutic useMiddle AgedPhenytoin/therapeutic useProthrombinRecurrenceSubarachnoid Hemorrhage/mortalitySubarachnoid Hemorrhage/prevention & control
Substances: See more » Antifibrinolytic AgentsCyclohexanecarboxylic AcidsFibrinolytic AgentsHydralazineMethyldopaPhenytoinFactor VFactor VIIProthrombinFactor IXFactor XFibrinFibrinogen
Year: 1973 PMID: 4718188 DOI: 10.1111/j.1600-0404.1973.tb01288.x
Source DB: PubMed Journal: Acta Neurol Scand ISSN: 0001-6314 Impact factor: 3.209